Literature DB >> 32966149

Clostridium Septicum Endogenous Endophthalmitis as the Initial Manifestation of Colorectal Carcinoma: Clinical Case Report and Literature Review.

José L Sanchez-Vicente1, Miguel Contreras-Díaz1, Fernando López-Herrero1, Ana Martínez-Borrego1, Antonio Galván-Ledesma1, Oscar Lozano-Bernal1, Mercedes García-Vazquez1, Juan De Las Morenas-Iglesias1, Manuel Caro-Magdaleno2.   

Abstract

PURPOSE: To describe the presentation and clinical course of a case of endogenous endophthalmitis caused by Clostridium septicum, an anaerobic and gram positive bacteria.
METHODS: Observational report of a clinical case presented in Spain. CLINICAL CASE: A 61-year-old male patient was referred to our hospital with a diagnosis of endophthalmitis of his left eye since ten days prior to presentation, and a history of poor response to medical treatment. Evisceration was performed, and C. septicum was isolated from a sample of the vitreous humor. Fourteen days after surgery, the patient returned with orbital cellulitis, and exenteration was performed. Forty-two days after initial presentation, colonoscopy revealed an adenocarcinoma of the proximal colon. Surgical resection of the tumor was performed, and clinical recovery was achieved.
CONCLUSIONS: iSystemic C. septicum infection without a traumatic cause has been associated with malignancy, although an initial presentation of endophthalmitis has rarely been reported. In cases of clostridial endogenous endophthalmitis, investigation for colorectal carcinoma is indicated.

Entities:  

Keywords:  Bacterial endophthalmitis; Clostridium septicum; colorectal carcinoma; endogenous endophthalmitis; evisceration; exenteration; infectious endophthalmitis

Mesh:

Year:  2020        PMID: 32966149     DOI: 10.1080/09273948.2020.1799039

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  1 in total

1.  [Endogenous endophthalmitis as initial manifestation of invasive pneumococcal disease].

Authors:  N Güemes-Villahoz; C Chocrón Benbunan; A R Romero Paternina; D Diaz-Valle; J Donate-López; M J Núñez-Orantos
Journal:  Rev Esp Quimioter       Date:  2021-01-28       Impact factor: 1.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.